
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cohort Plc | LSE:CHRT | London | Ordinary Share | GB00B0YD2B94 | ORD 10P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
1,522.00 | 1,532.00 | 1,568.00 | 1,522.00 | 1,560.00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Consulting Svcs,nec | 202.53M | 15.32M | 0.3283 | 46.60 | 731.46M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
16:35:26 | UT | 12,230 | 1,528.00 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
29/5/2025 | 12:03 | ALNC | ![]() |
29/5/2025 | 07:00 | UK RNS | Cohort PLC Full Year Trading Update |
12/5/2025 | 15:59 | UK RNS | Cohort PLC Block Listing Application |
06/5/2025 | 14:59 | ALNC | ![]() |
06/5/2025 | 14:00 | UK RNS | Cohort PLC Contract Win (Replacement) |
01/5/2025 | 14:18 | ALNC | ![]() |
01/5/2025 | 09:00 | UK RNS | Cohort PLC Contract win |
01/5/2025 | 07:00 | UK RNS | Cohort PLC Total Voting Rights |
24/4/2025 | 12:12 | UK RNS | Cohort PLC Director/PDMR Shareholding |
09/4/2025 | 15:05 | UK RNS | Cohort PLC Director/PDMR Shareholding |
Cohort (CHRT) Share Charts1 Year Cohort Chart |
|
1 Month Cohort Chart |
Intraday Cohort Chart |
Date | Time | Title | Posts |
---|---|---|---|
14/6/2025 | 17:22 | Cohort - Right place at the right Time | 796 |
10/4/2018 | 12:14 | Charts | - |
24/6/2013 | 19:14 | ADVFN Charts: Suggestions for Improvements. | 13 |
28/3/2006 | 15:31 | Chart Help Needed | 16 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
2025-06-19 15:35:26 | 1,528.00 | 12,230 | 186,874.40 | UT |
2025-06-19 15:29:50 | 1,524.00 | 1 | 15.24 | O |
2025-06-19 15:29:50 | 1,530.00 | 111 | 1,698.30 | AT |
2025-06-19 15:29:50 | 1,530.00 | 96 | 1,468.80 | AT |
2025-06-19 15:29:44 | 1,528.00 | 114 | 1,741.92 | AT |
Top Posts |
---|
Posted at 19/6/2025 09:20 by Cohort Daily Update Cohort Plc is listed in the Business Consulting Svcs,nec sector of the London Stock Exchange with ticker CHRT. The last closing price for Cohort was 1,568p.Cohort currently has 46,649,226 shares in issue. The market capitalisation of Cohort is £713,733,158. Cohort has a price to earnings ratio (PE ratio) of 46.60. This morning CHRT shares opened at 1,560p |
Posted at 13/6/2025 11:55 by scottishfield Defense shares in a little dip currently. I'm holding all mine (incl CHRT). |
Posted at 13/6/2025 11:54 by whites123 Israel / Iran is only going to bolster CHRT and with the Government Defense spending review I am VERY surprised that CHRT is not flying.Maybe once the impact of Israel / Iran is fully digested we will likely see a huge immediate increase. |
Posted at 29/5/2025 07:49 by edmonda "FY25 trading update and a new record order book" - new research note (freely accessible) and audio summary here: In a Trading Update for the year to 30 April 2025, Cohort reports strong growth and a record closing order book of £615m, materially surpassing the previous record of £518.7m. The Group expects FY25 performance in line with market expectations, underpinned by strength in the Communications & Intelligence (C&I) division, whilst Sensors & Effectors (S&E) performance was broadly comparable to FY24. Order intake was c.£285m (1.1x revenue) and excludes an additional £80m of orders acquired with EM Solutions; the comparable FY24 figure of £387m which included the single Royal Navy order for £135m, which if excluded indicates 12%YoY growth. Closing net funds stood at £5m, ahead of Group expectations following the acquisition of EM Solutions for £75m. The recent disposal of the transport operations of SEA will reduce the non-defence component of revenue to only 3%. The Group reports continuing demand for its products and services, notably in light of the ongoing conflict in Eastern Europe and tensions in Indo-Pacific, whilst also awaiting the imminent outcome of the UK’s Strategic Defence Review. The addition of EM Solutions also aligns with defence initiatives in Australia and Indo-Pacific, backed by the AUKUS strategic alliance. Whilst noting the strength of the share price, our outlook is unchanged for now. FY25 reporting in July will provide the opportunity to both review forecasts and reassess our Fair Value calculation. |
Posted at 16/5/2025 09:29 by wad collector Doesn't seem to be stopping. But seems likely that at some point there will be a sharp drop before a gradual rise again. Still holding for now , this was meant to be an investment not a trading share! |
Posted at 24/1/2025 15:24 by mello2024 Just to let shareholders and prospective investors know that CHRT will be presenting on the MelloMonday webinar starting at 4.30pm on the 27th January, 2025. The programme for the evening is as follows: 4.30pm Interview with Fund Manager, Katen Patel 5:00pm Company presentation from Helios Underwriting plc 5:40pm Company presentation from Solvonis Therapeutics (formerly Graft Polymer) 6.20pm Educational session 6:35pm Company presentation from Cohort plc 7:05pm BASH (Buy, Avoid, Sell Hold) Panel featuring Kevin Taylor and Mark Simpson Tickets are still available and if you would like one at half price then enter the code MMTADVFN50. |
Posted at 20/1/2025 08:53 by estienne Cohort is a collection of specialist defence companies on whom the likes of BAe and Thales rely in order to integrate their systems and meet performance requirements. QinetiQ is different because its main role in the UK is the Long Term Partner agreement with MoD under which it provides consultancy services but not products. In contrast BAe & Thales are prime contractors whose share prices are likely to swing with sentiment within the defence industry. The Cohort share price will not be subject to sentiment to the same extent and will increase as it continues to provide the primes with much needed support |
Posted at 13/12/2024 18:14 by xtrmntr From the IC.There have been some recent jitters amongst defence stocks after US president-elect Donald Trump called for an "immediate ceasefire" in Ukraine. But the war has highlighted long-term underinvestment in defence and security in Europe, as has the incoming US administration's more antagonistic view of Nato. Aim-traded mini-defence conglomerate Cohort (CHRT) is navigating this demand context well, and is benefiting from heightened tensions in the Asia-Pacific and Middle East, evidenced by the company's disclosure of a record order book and revenue growth of a quarter in its first half. Sales to the UK Ministry of Defence (MOD), which contributed an increased 56 per cent of total revenue in the half, drove the revenue and profit performance. Both the communications and intelligence and sensors and effectors units delivered robust adjusted operating profit growth, as profit jumped 69 per cent to £10.1mn. The net margin improved from 6.4 per cent to 8.5 per cent, with progress being made towards management's medium-term mid-teen target. Encouragingly, management expects its Portuguese communications systems business EID, which has been loss-making over the past couple of years, to return to profit over the full year on the back of "long-awaited" naval orders. The order book sat at £541mn at the period-end, up from £519mn in April. and representing an order cover of 99 per cent of the analyst consensus for annual revenue. Order intake of £139mn was 1.2 times revenue in the half. Meanwhile, the £74mn acquisition of high-margin naval defence communications business EM Solutions (the transaction is expected to complete imminently) provides a tasty long-term opportunity. Clients include the Australian navy, Norwegian navy and Dutch defence department. The deal was part-funded through a £41mn share placing and retail offer. Chief executive Andy Thomas said the company was in discussions with more "big potential customers" for EM Solutions. Net funds improved by £15mn to £37.9mn, although a net cash outflow is anticipated in the second half, given capex, working capital movements and the EM Solutions purchase. Cohort trades on 20 times forward consensus earnings, a higher rating than at Chemring (CHG), as well as bigger sector beasts BAE Systems (BA.) and Lockheed Martin (US:LMT). The share price has more than doubled over the past year. But, as analysts at Shore Capital argued, Cohort is "visibly becoming a strategic supplier with clients, justifying a premium valuation", and there is an expectation of "strong news flow continuing for shareholders". We remain bullish on the outlook. Buy. |
Posted at 12/12/2024 09:15 by estienne Cohort own some very necessary military tools and I think the share price will double in the near term |
Posted at 16/11/2024 17:35 by tournesol I sold CHRT at a substantial profit to avoid the potential risk of a change in the IHT treatment of AIM listed stocks which could have dragged on the share price That risk seems to have receded. I'm now minded to re-enter. |
Posted at 26/9/2024 21:38 by wad collector Robertball21 Jul '23 - 23:00 - 487 of 6230 2 0 The share price will only change if there is a takeover bid or serious good news Err , there are other possible reasons the share price may change. And given that the share price must have been about 450p then , are you saying that it has doubled because of the former or the latter? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions